<html>
<head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
</head>
<body text="#000000" bgcolor="#f9f9fa">
<div class="detail">
<div class="info"> <span class="date"><font
style="vertical-align: inherit;"><font
style="vertical-align: inherit;">05/20/2021</font></font></span>
</div>
<div class="caption"><font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">Pfizer / BioNTech illegal
because experimental: New Zealand High Court ruling</font></font></div>
<div class="author">
<div class="pic"> <img
src="https://www.worldlifeo.com/upload/members/silvia-pedrazzini-e15e00605d7457873d1c6f6474d23590-s.jpg"
class="img-circle" alt="S. Pedrazzini" width="40"> <span
class="name"><font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">S. Pedrazzini</font></font></span>
</div>
</div>
</div>
<div class="description">
<p><em><font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">Thanks to the ruling of
the High Court, the Government of New Zealand yesterday
modified the law on the distribution of the Pfizer /
BioNTech vaccine; </font><font style="vertical-align:
inherit;">the ruling states that access to the vaccine was
illegal and in violation of the Medicines Act as it was
still experimental.</font></font></em></p>
<p><font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">The Nga Kaitiaki Tuku Ihu
Medical Action Society had turned to the High Court arguing
that the Pfizer vaccine had not completed its </font><font
style="vertical-align: inherit;"> clinical </font></font><strong><a
href="https://clinicaltrials.gov/ct2/show/NCT04368728"><font
style="vertical-align: inherit;"><font
style="vertical-align: inherit;">trial</font></font></a></strong><font
style="vertical-align: inherit;"><font style="vertical-align:
inherit;"> phase </font><font style="vertical-align:
inherit;">and should not be made available to the wider
population in accordance with section 23 of the act. </font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
In fact, the vaccine has been approved for more than
two-thirds of the New Zealand population, although the
primary clinical trial for the vaccine still to be completed
is scheduled for April 2023. </font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
KTI has released an </font><font style="vertical-align:
inherit;"> open </font></font><strong><a
href="https://kti.org.nz/?p=361"><font
style="vertical-align: inherit;"><font
style="vertical-align: inherit;">letter</font></font></a></strong><font
style="vertical-align: inherit;"><font style="vertical-align:
inherit;"> signed by 43 New Zealand doctors outlining the
case and expressed concern about the promotion of the
vaccine despite the lack of evidence to prove its safety.</font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
The letter shows that "No one at the moment knows how safe
or effective this new mRNA technology is in the medium and
long term. Highly credible medical experts around the world,
and even some vaccine developers themselves, foresee
problems and raise urgent concerns from report. </font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
Forcing patients or workers to receive drugs, medicines or
vaccines that are still being tested would constitute a
significant precedent doctor, which would be contrary to all
international codes of medical ethics from the 1947
Nuremberg Code and the Declaration of Helsinki of the 1952 "
</font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
The High Court ruled in favor of KTI and the deed received
an </font><font style="vertical-align: inherit;"> immediate
</font></font><strong><a
href="https://www.beehive.govt.nz/release/technical-amendment-medicines-act"><font
style="vertical-align: inherit;"><font
style="vertical-align: inherit;">amendment</font></font></a></strong><font
style="vertical-align: inherit;"><font style="vertical-align:
inherit;"> , in fact yesterday the </font><strong><a
href="https://www.parliament.nz/en/pb/bills-and-laws/bills-proposed-laws/document/BILL_111377/medicines-amendment-bill"><font
style="vertical-align: inherit;">law</font></a></strong><font
style="vertical-align: inherit;"> was introduced and
approved</font></font><strong></strong><font
style="vertical-align: inherit;"><font style="vertical-align:
inherit;">. </font></font><br>
<font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">
Section 23 (1) of the Medicines Act initially stipulated
that the provisional consent given by the Minister of Health
to the supply of a new medicine was to be used on a limited
basis and only for the treatment of a limited number of
patients.</font></font></p>
<p><strong><em><font style="vertical-align: inherit;"><font
style="vertical-align: inherit;">We thank you for the
diffusion of our contents, we ask only to mention OMV as
the source.</font></font></em></strong></p>
</div>
</body>
</html>